800 related articles for article (PubMed ID: 21996205)
61. Cross-sectional study of BK virus infection in pediatric kidney transplant recipients.
Fogeda M; Muñoz P; Luque A; Morales MD; Bouza E;
Pediatr Transplant; 2007 Jun; 11(4):394-401. PubMed ID: 17493219
[TBL] [Abstract][Full Text] [Related]
62. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.
Saad ER; Bresnahan BA; Cohen EP; Lu N; Orentas RJ; Vasudev B; Hariharan S
Transplantation; 2008 Mar; 85(6):850-4. PubMed ID: 18360267
[TBL] [Abstract][Full Text] [Related]
63. Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.
Soleymanian T; Rasulzadegan MH; Sotoodeh M; Ganji MR; Naderi G; Amin M; Saddadi F; Hakemi M; Najafi I
Exp Clin Transplant; 2010 Dec; 8(4):297-302. PubMed ID: 21143095
[TBL] [Abstract][Full Text] [Related]
64. Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.
Solis M; Velay A; Porcher R; Domingo-Calap P; Soulier E; Joly M; Meddeb M; Kack-Kack W; Moulin B; Bahram S; Stoll-Keller F; Barth H; Caillard S; Fafi-Kremer S
J Am Soc Nephrol; 2018 Jan; 29(1):326-334. PubMed ID: 29042457
[TBL] [Abstract][Full Text] [Related]
65. Early BK polyomavirus (BKV) reactivation in donor kidney is a risk factor for development of BKV-associated nephropathy.
Saundh BK; Baker R; Harris M; Welberry Smith MP; Cherukuri A; Hale A
J Infect Dis; 2013 Jan; 207(1):137-41. PubMed ID: 23100561
[TBL] [Abstract][Full Text] [Related]
66. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
67. Impact of combined acute rejection on BK virus-associated nephropathy in kidney transplantation.
Kim YJ; Jeong JC; Koo TY; Kwon HY; Han M; Jeon HJ; Ahn C; Yang J
J Korean Med Sci; 2013 Dec; 28(12):1711-5. PubMed ID: 24339698
[TBL] [Abstract][Full Text] [Related]
68. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy.
Viscount HB; Eid AJ; Espy MJ; Griffin MD; Thomsen KM; Harmsen WS; Razonable RR; Smith TF
Transplantation; 2007 Aug; 84(3):340-5. PubMed ID: 17700158
[TBL] [Abstract][Full Text] [Related]
69. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.
Alméras C; Vetromile F; Garrigue V; Szwarc I; Foulongne V; Mourad G
Transpl Infect Dis; 2011 Apr; 13(2):101-8. PubMed ID: 21371220
[TBL] [Abstract][Full Text] [Related]
70. Prevalence of BK virus replication among recipients of solid organ transplants.
Muñoz P; Fogeda M; Bouza E; Verde E; Palomo J; Bañares R;
Clin Infect Dis; 2005 Dec; 41(12):1720-5. PubMed ID: 16288394
[TBL] [Abstract][Full Text] [Related]
71. BK virus-associated viruria and viremia in a patient with lymphangioleiomyomatosis after lung re-transplantation: A case report and review of the literature on BK virus infection post-lung transplantation.
Okumura J; Nakahara Y; Nakaguro M; Shindo Y; Hase T; Wakahara K; Hashimoto N; Hasegawa Y
J Infect Chemother; 2019 Oct; 25(10):820-824. PubMed ID: 31027885
[TBL] [Abstract][Full Text] [Related]
72. A kidney transplant recipient with renal medullary viral cytopathic changes.
Ramanan P; Timmerman EA; Fidler ME; Amer H; Pritt BS; Schwab DA; Batterman HJ; Binnicker MJ
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27925350
[TBL] [Abstract][Full Text] [Related]
73. BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen.
Geddes CC; Gunson R; Mazonakis E; Wan R; Thomson L; Clancy M; Carman WF
Transpl Infect Dis; 2011 Apr; 13(2):109-16. PubMed ID: 21457419
[TBL] [Abstract][Full Text] [Related]
74. Combined measurement of serum DNA and urine VP1 messenger RNA in monitoring BK virus replication in kidney graft recipients.
Astegiano S; Bergallo M; Terlizzi ME; Sidoti F; Gambarino S; Messina M; Costa C; Segoloni GP; Cavallo R
Transplant Proc; 2011 May; 43(4):1052-4. PubMed ID: 21620051
[TBL] [Abstract][Full Text] [Related]
75. Prospective monitoring of BK virus reactivation in renal transplant recipients in North India.
Thakur R; Arora S; Nada R; Minz M; Joshi K
Transpl Infect Dis; 2011 Dec; 13(6):575-83. PubMed ID: 21507160
[TBL] [Abstract][Full Text] [Related]
76. Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection.
Jha A; Ahmed W; Pakkyara A; Shaheen F; Al Salmi I
Saudi J Kidney Dis Transpl; 2018; 29(5):1073-1081. PubMed ID: 30381503
[TBL] [Abstract][Full Text] [Related]
77. Lower prevalence of BK virus infection in African American renal transplant recipients: a prospective study.
Sood P; Senanayake S; Sujeet K; Medipalli R; Saad E; Vasudev B; Bresnahan BA; Johnson CP; Hariharan S
Transplantation; 2012 Feb; 93(3):291-6. PubMed ID: 22179402
[TBL] [Abstract][Full Text] [Related]
78. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
[TBL] [Abstract][Full Text] [Related]
79. BK virus nephritis after renal transplantation.
Hariharan S
Kidney Int; 2006 Feb; 69(4):655-62. PubMed ID: 16395271
[TBL] [Abstract][Full Text] [Related]
80. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
